Lexaria Bioscience gets AUD 3.67 million R&D tax credit
Lexaria Bioscience received an AUD 3,666,611.98 Australian R&D tax credit, or USD 2.6 million, tied to its GLP-1 clinical study.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.